Crockford G P, Bishop D T, Barrett J H
Genetic Epidemiology Division, Cancer Research UK Clinical Centre in Leeds, Cancer Genetics Building, St James's University Hospital, Beckett Street, Leeds, United Kingdom.
BMC Genet. 2003 Dec 31;4 Suppl 1(Suppl 1):S79. doi: 10.1186/1471-2156-4-S1-S79.
Discrete (qualitative) data segregation analysis may be performed assuming the liability model, which involves an underlying normally distributed quantitative phenotype. The appropriateness of the liability model for complex traits is unclear. The Genetic Analysis Workshop 13 simulated data provides measures on systolic blood pressure, a highly complex trait, which may be dichotomized into a discrete trait (hypertension). We perform segregation analysis under the liability model of hypertensive status as a qualitative trait and compare this with results using systolic blood pressure as a quantitative trait (without prior knowledge at that stage of the true underlying simulation model) using 1050 pedigrees ascertained from four replicates on the basis of at least one affected member. Both analyses identify models with major genes and polygenic components to explain the family aggregation of systolic blood pressure. Neither of the methods estimates the true parameters well (as the true model is considerably more complicated than those considered for the analysis), but both identified the most complicated model evaluated as the preferred model. Segregation analysis of complex diseases using relatively simple models is unlikely to provide accurate parameter estimates but is able to indicate major gene and/or polygenic components in familial aggregation of complex diseases.
离散(定性)数据分离分析可以在假定易患性模型的情况下进行,该模型涉及一个潜在的正态分布定量表型。易患性模型对于复杂性状的适用性尚不清楚。遗传分析研讨会13的模拟数据提供了关于收缩压的测量值,收缩压是一种高度复杂的性状,可将其二分法化为离散性状(高血压)。我们在将高血压状态作为定性性状的易患性模型下进行分离分析,并将其与使用收缩压作为定量性状的结果进行比较(在该阶段没有关于真实潜在模拟模型的先验知识),使用基于至少一名患病成员从四个重复样本中确定的1050个家系。两种分析都识别出具有主基因和多基因成分的模型来解释收缩压的家族聚集性。两种方法都不能很好地估计真实参数(因为真实模型比分析中考虑的模型要复杂得多),但两者都将评估的最复杂模型识别为首选模型。使用相对简单的模型对复杂疾病进行分离分析不太可能提供准确的参数估计,但能够指出复杂疾病家族聚集性中的主基因和/或多基因成分。